{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:05:39Z","timestamp":1649030739177},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2010,5,8]],"date-time":"2010-05-08T00:00:00Z","timestamp":1273276800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HNO"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s00106-009-2068-z","type":"journal-article","created":{"date-parts":[[2010,5,6]],"date-time":"2010-05-06T17:24:37Z","timestamp":1273166677000},"page":"1025-1030","source":"Crossref","is-referenced-by-count":5,"title":["Intratympanale Glukokortikoidtherapie bei H\u00f6rsturz"],"prefix":"10.1007","volume":"58","author":[{"given":"S.K.","family":"Plontke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,8]]},"reference":[{"key":"2068_CR1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/MLG.0b013e3181585428","volume":"118","author":"Ahn","year":"2008","unstructured":"Ahn JH, Yoo MH, Yoon TH, Chung JW (2008) Can intratympanic dexamethasone added to systemic steroids improve hearing outcome in patients with sudden deafness? Laryngoscope 118:279\u2013282","journal-title":"Laryngoscope"},{"key":"2068_CR2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/000348940010900105","volume":"109","author":"Alzamil","year":"2000","unstructured":"Alzamil KS, Linthicum FH Jr (2000) Extraneous round window membranes and plugs: possible effect on intratympanic therapy. Ann Otol Rhinol Laryngol 109:30\u201332","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"2068_CR3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000082575","volume":"10","author":"Arnold","year":"2005","unstructured":"Arnold W, Senn P, Hennig M et al (2005) Novel slow- and fast-type drug release round-window microimplants for local drug application to the cochlea: an experimental study in guinea pigs. Audiol Neurootol 10:53\u201363","journal-title":"Audiol Neurootol"},{"key":"2068_CR4","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s001060170078","volume":"49","author":"Bachmann","year":"2001","unstructured":"Bachmann G, Su J, Zumegen C et al (2001) Permeability of the round window membrane for prednisolone-21-hydrogen succinate. Prednisolone content of the perilymph after local administration vs. systemic injection. HNO 49:538\u2013542","journal-title":"HNO"},{"key":"2068_CR5","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/01.mao.0000185052.07513.5a","volume":"26","author":"Banerjee","year":"2005","unstructured":"Banerjee A, Parnes LS (2005) Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss. Otol Neurotol 26:878\u2013881","journal-title":"Otol Neurotol"},{"key":"2068_CR6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/MAO.0b013e318168da7a","volume":"29","author":"Battaglia","year":"2008","unstructured":"Battaglia A, Burchette R, Cueva R (2008) Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol 29:453\u2013460","journal-title":"Otol Neurotol"},{"key":"2068_CR7","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.otohns.2005.01.024","volume":"132","author":"Battista","year":"2005","unstructured":"Battista RA (2005) Intratympanic dexamethasone for profound idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 132:902\u2013905","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2068_CR8","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/MAO.0b013e31815aee21","volume":"28","author":"Bird","year":"2007","unstructured":"Bird PA, Begg EJ, Zhang M et al (2007) Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Otol Neurotol 28:1124\u20131130","journal-title":"Otol Neurotol"},{"key":"2068_CR9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00129492-200101000-00005","volume":"22","author":"Chandrasekhar","year":"2001","unstructured":"Chandrasekhar SS (2001) Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol 22:18\u201323","journal-title":"Otol Neurotol"},{"key":"2068_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2005.09.003","volume":"110","author":"Chen","year":"2005","unstructured":"Chen Z, Kujawa SG, McKenna MJ et al (2005) Inner ear drug delivery via a reciprocating perfusion system in the guinea pig. J Control Release 110:1\u201319","journal-title":"J Control Release"},{"key":"2068_CR11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/01.mlg.0000205183.29986.f6","volume":"116","author":"Choung","year":"2006","unstructured":"Choung YH, Park K, Shin YR, Cho MJ (2006) Intratympanic dexamethasone injection for refractory sudden sensorineural hearing loss. Laryngoscope 116:747\u2013752","journal-title":"Laryngoscope"},{"key":"2068_CR12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000093093","volume":"68","author":"Dallan","year":"2006","unstructured":"Dallan I, Bruschini L, Nacci A et al (2006) Transtympanic steroids as a salvage therapy in sudden hearing loss: preliminary results. ORL J Otorhinolaryngol Relat Spec 68:247\u2013252","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"2068_CR13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MAO.0b013e3181c34f18","volume":"31","author":"Dallan","year":"2010","unstructured":"Dallan I, De Vito A, Fattori B et al (2010) Intratympanic methylprednisolone in refractory sudden hearing loss: a 27-patient case series with univariate and multivariate analysis. Otol Neurotol 31:25\u201330","journal-title":"Otol Neurotol"},{"key":"2068_CR14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1067\/mhn.2001.117162","volume":"125","author":"Gianoli","year":"2001","unstructured":"Gianoli GJ, Li JC (2001) Transtympanic steroids for treatment of sudden hearing loss. Otolaryngol Head Neck Surg 125:142\u2013146","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2068_CR15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00405-004-0772-6","volume":"262","author":"Gouveris","year":"2005","unstructured":"Gouveris H, Selivanova O, Mann W (2005) Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy. Eur Arch Otorhinolaryngol 262:131\u2013134","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2068_CR16","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.otohns.2009.06.084","volume":"141","author":"Han","year":"2009","unstructured":"Han CS, Park JR, Boo SH et al (2009) Clinical efficacy of initial intratympanic steroid treatment on sudden sensorineural hearing loss with diabetes. Otolaryngol Head Neck Surg 141:572\u2013578","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2068_CR17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.mlg.0000245058.11866.15","volume":"117","author":"Haynes","year":"2007","unstructured":"Haynes DS, O\u2019Malley M, Cohen S et al (2007) Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 117:3\u201315","journal-title":"Laryngoscope"},{"key":"2068_CR18","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.otohns.2004.09.138","volume":"132","author":"Herr","year":"2005","unstructured":"Herr BD, Marzo SJ (2005) Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 132:527\u2013531","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2068_CR19","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/00005537-200407000-00010","volume":"114","author":"Ho","year":"2004","unstructured":"Ho HG, Lin HC, Shu MT et al (2004) Effectiveness of intratympanic dexamethasone injection in sudden-deafness patients as salvage treatment. Laryngoscope 114:1184\u20131189","journal-title":"Laryngoscope"},{"key":"2068_CR20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000241894","volume":"14","author":"Hu","year":"2009","unstructured":"Hu A, Parnes LS (2009) Intratympanic steroids for inner ear disorders: a review. Audiol Neurootol 14:373\u2013382","journal-title":"Audiol Neurootol"},{"key":"2068_CR21","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/01.mao.0000224092.79635.ee","volume":"27","author":"Kakehata","year":"2006","unstructured":"Kakehata S, Sasaki A, Oji K et al (2006) Comparison of intratympanic and intravenous dexamethasone treatment on sudden sensorineural hearing loss with diabetes. Otol Neurotol 27:604\u2013608","journal-title":"Otol Neurotol"},{"key":"2068_CR22","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/MAO.0b013e31802fba7a","volume":"28","author":"Kilic","year":"2007","unstructured":"Kilic R, Safak MA, Oguz H et al (2007) Intratympanic methylprednisolone for sudden sensorineural hearing loss. Otol Neurotol 28:312\u2013316","journal-title":"Otol Neurotol"},{"key":"2068_CR23","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00129492-200107000-00011","volume":"22","author":"Kopke","year":"2001","unstructured":"Kopke RD, Hoffer ME, Wester D et al (2001) Targeted topical steroid therapy in sudden sensorineural hearing loss. Otol Neurotol 22:475\u2013479","journal-title":"Otol Neurotol"},{"key":"2068_CR24","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00405-004-0876-z","volume":"262","author":"Lautermann","year":"2005","unstructured":"Lautermann J, Sudhoff H, Junker R (2005) Transtympanic corticoid therapy for acute profound hearing loss. Eur Arch Otorhinolaryngol 262:587\u2013591","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2068_CR25","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/003655402_000028037","volume":"122","author":"Lefebvre","year":"2002","unstructured":"Lefebvre PP, Staecker H (2002) Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: a pilot study. Acta Otolaryngol 122:698\u2013702","journal-title":"Acta Otolaryngol"},{"key":"2068_CR26","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s10162-006-0034-y","volume":"7","author":"Mynatt","year":"2006","unstructured":"Mynatt R, Hale SA, Gill RM et al (2006) Demonstration of a longitudinal concentration gradient along scala tympani by sequential sampling of perilymph from the cochlear apex. J Assoc Res Otolaryngol 7:182\u2013193","journal-title":"J Assoc Res Otolaryngol"},{"key":"2068_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005537-199907001-00001","volume":"109","author":"Parnes","year":"1999","unstructured":"Parnes LS, Sun AH, Freeman DJ (1999) Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 109:1\u201317","journal-title":"Laryngoscope"},{"key":"2068_CR28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.otohns.2007.01.022","volume":"137","author":"Plaza","year":"2007","unstructured":"Plaza G, Herraiz C (2007) Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy. Otolaryngol Head Neck Surg 137:74\u201378","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2068_CR29","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1080\/00016480510037898","volume":"125","author":"Plontke","year":"2005","unstructured":"Plontke S, Lowenheim H, Preyer S et al (2005) Outcomes research analysis of continuous intratympanic glucocorticoid delivery in patients with acute severe to profound hearing loss: basis for planning randomized controlled trials. Acta Otolaryngol 125:830\u2013839","journal-title":"Acta Otolaryngol"},{"key":"2068_CR30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/MAO.0b013e318161aaae","volume":"29","author":"Plontke","year":"2008","unstructured":"Plontke SK, Biegner T, Kammerer B et al (2008) Dexamethasone concentration gradients along scala tympani after application to the round window membrane. Otol Neurotol 29:401\u2013406","journal-title":"Otol Neurotol"},{"key":"2068_CR31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/lary.20074","volume":"119","author":"Plontke","year":"2009","unstructured":"Plontke SK, Lowenheim H, Mertens J et al (2009) Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy. Laryngoscope 119:359\u2013369","journal-title":"Laryngoscope"},{"key":"2068_CR32","first-page":"CD008080","volume":"4","author":"Plontke","year":"2009","unstructured":"Plontke SK, Meisner C, Caye-Thomasen P et al (2009) Intratympanic glucocorticoids for sudden sensorineural hearing loss (protocol). Cochrane Database Syst Rev Issue 4: CD008080. DOI: 10.1002\/14651858.CD008080","journal-title":"Cochrane Database Syst Rev Issue"},{"key":"2068_CR33","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/MAO.0b013e318173fcea","volume":"29","author":"Plontke","year":"2008","unstructured":"Plontke SK, Mikulec AA, Salt AN (2008) Rapid clearance of methylprednisolone after intratympanic application in humans. Comment on: Bird PA, Begg EJ, Zhang M, et al (2007) Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Otol Neurotol 28:1124\u20131130. Otol Neurotol 29:732\u2013733","journal-title":"Otol Neurotol"},{"key":"2068_CR34","first-page":"149","volume":"59","author":"Plontke","year":"2002","unstructured":"Plontke SK, Plinkert PK, Plinkert B et al (2002) Transtympanic endoscopy for drug delivery to the inner ear using a new microendoscope. Adv Otorhinolaryngol 59:149\u2013155","journal-title":"Adv Otorhinolaryngol"},{"key":"2068_CR35","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/MAO.0b013e31818b6298","volume":"30","author":"Rauch","year":"2009","unstructured":"Rauch SD, Reda DJ (2009) Combined therapy (intratympanic dexamethasone + high-dose prednisone taper) for idiopathic sudden sensorineural hearing loss. Otol Neurotol 30:254\u2013255","journal-title":"Otol Neurotol"},{"key":"2068_CR36","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.otohns.2006.03.035","volume":"135","author":"Roebuck","year":"2006","unstructured":"Roebuck J, Chang CY (2006) Efficacy of steroid injection on idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 135:276\u2013279","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2068_CR37","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000241892","volume":"14","author":"Salt","year":"2009","unstructured":"Salt AN, Plontke SK (2009) Principles of local drug delivery to the inner ear. Audiol Neurootol 14:350\u2013360","journal-title":"Audiol Neurootol"},{"key":"2068_CR38","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/01.mao.0000185050.69394.48","volume":"26","author":"Selivanova","year":"2005","unstructured":"Selivanova OA, Gouveris H, Victor A et al (2005) Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Meniere\u2019s-associated sudden sensorineural hearing loss. Otol Neurotol 26:890\u2013895","journal-title":"Otol Neurotol"},{"key":"2068_CR39","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1177\/014556139607500806","volume":"75","author":"Silverstein","year":"1996","unstructured":"Silverstein H, Choo D, Rosenberg SI et al (1996) Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report). Ear Nose Throat J 75:468\u2013471, 474, 476","journal-title":"Ear Nose Throat J"},{"key":"2068_CR40","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.otohns.2005.05.015","volume":"133","author":"Slattery","year":"2005","unstructured":"Slattery WH, Fisher LM, Iqbal Z et al (2005) Intratympanic steroid injection for treatment of idiopathic sudden hearing loss. Otolaryngol Head Neck Surg 133:251\u2013259","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2068_CR41","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0378-5955(99)00115-X","volume":"136","author":"Stover","year":"1999","unstructured":"Stover T, Yagi M, Raphael Y (1999) Cochlear gene transfer: round window versus cochleostomy inoculation. Hear Res 136:124\u2013130","journal-title":"Hear Res"},{"key":"2068_CR42","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1080\/00016480601126952","volume":"127","author":"Van","year":"2007","unstructured":"Van Wijck F, Staecker H, Lefebvre PP (2007) Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment. Acta Otolaryngol 127:1012\u20131017","journal-title":"Acta Otolaryngol"},{"key":"2068_CR43","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.otohns.2005.03.081","volume":"134","author":"Xenellis","year":"2006","unstructured":"Xenellis J, Papadimitriou N, Nikolopoulos T et al (2006) Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Otolaryngol Head Neck Surg 134:940\u2013945","journal-title":"Otolaryngol Head Neck Surg"}],"container-title":["HNO"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-009-2068-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00106-009-2068-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-009-2068-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T01:11:36Z","timestamp":1559092296000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00106-009-2068-z"}},"subtitle":["Intratympanic glucocorticoid therapy of sudden hearing loss"],"short-title":[],"issued":{"date-parts":[[2010,5,8]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["2068"],"URL":"https:\/\/doi.org\/10.1007\/s00106-009-2068-z","relation":{},"ISSN":["0017-6192","1433-0458"],"issn-type":[{"value":"0017-6192","type":"print"},{"value":"1433-0458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,8]]}}}